Neoadjuvant Atezolizumab in Patients With Non-Metastatic Resectable High-Risk Cutaneous Melanoma

Investigator: Nestor Esnaola, MD

Study Coordinator: Safiya Joseph

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT04020809

Phone: 203.308.8567

Protocol Number: Pro00021957

Description

The purpose of this research study is to see whether using atezolizumab before surgery is safe and does not cause side effects that delay surgery in participants with cutaneous melanoma that has not spread to other areas of the body (non-metastatic) and can be removed by surgery (resectable) but has a higher risk of coming back after surgery (high-risk).
More to Explore